ARCHIVES

JCO Retracts Key Duke Genomics Paper; Duke Shuts Down Three Phase II Trials

This article is from The Cancer Letter archive.

Vol. 36 No. 42 | November 19, 2010

Download PDF Visit The Full Archive

Related Articles

In Brief: Shubik, Rhoads, Dixon Affiliations With Industry Lister By House Subcommittee

June 11, 1976

Trial: Decitabine Improves Survival in Myeloid Leukemia

July 29, 2011

ASCO Annual Meeting Abstracts Posted Online

May 28, 2010

Advisers Fume Over Preventions Budget Cut; NIH Probably Did It

May 22, 1992

Continous Hormone Therapy Superior To Intermittent In 17-Year SWOG Study

June 29, 2012

In Brief: Angel Bradley, NCAB Member, Dies; Three State Colorectal Cancer Screening Effort Big Success

July 5, 1985